Raleigh – September 17, 2026 -- Endpoint Clinical L.P., a portfolio company of Arsenal Capital Partners, has acquired Boston-based Bluefin, a clinical supply forecasting and planning technology provider, expanding Endpoint's footprint from randomization and trial supply management (RTSM) into upstream supply chain planning.

Jersey City, N.J. – September 17, 2026 -- Tenon Medical, Inc. (NASDAQ: TNON) has closed a warrant inducement agreement generating $2,872,338.58 in gross proceeds from an institutional investor exercising 572,179 outstanding warrants in full.

Institutional investor exercises warrants for immediate cash proceeds

The exercising holder converted 572,179 existing warrants into common stock, delivering gross cash proceeds of $2,872,338.58 to Tenon before deducting advisor fees and other expenses.

Short Hills, N.J. – September 17, 2026 -- Doceree has launched Intent Powered HCP Suite, extending its real-time clinical signal technology into Connected TV, LinkedIn and programmatic advertising, three channels the company says still rely on claims data that lags weeks behind actual prescribing decisions.

San Francisco – September 17, 2026 -- Deloitte has expanded its alliance with Salesforce to launch FastForward for Life Sciences, a preconfigured CRM accelerator that cuts implementation timelines to four to six months, twice as fast as traditional customized transformations.

NEW YORK – September 17, 2026 -- Inductive Bio has launched Indy, an AI medicinal chemistry agent that scored 89% accuracy on 84 real-program dose-response curves, versus 48% for Claude Opus 5 and 39% for GPT-5.6 Sol run at maximum effort settings.

Shanghai – September 17, 2026 -- MoleculeMind, an AI-native bioengineering infrastructure company, has had research on its reactive atomistic modeling platform QuantaMind published in Science Advances, demonstrating Density Functional Theory (DFT)-level accuracy in simulating 10,000-atom biomolecular systems over tens-of-nanosecond timescales.

Plymouth Meeting, Pa. – September 17, 2026 -- The National Comprehensive Cancer Network (NCCN) Oncology Research Program has awarded funding for four quality improvement projects targeting metastatic prostate cancer (mPCA) care, backed by Pfizer Global Medical Grants (GMG).

Seoul, South Korea – September 17, 2026 -- Yuyu Pharma has completed an 869-kilowatt (kW) solar installation at its Korean manufacturing facility, lifting total on-site solar capacity to approximately 1 megawatt (MW) and covering more than 30% of the plant's electricity needs.

San Rafael, Calif. – September 17, 2026 -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has appointed Robert Plenge, M.D., Ph.D., to its Board of Directors, effective September 10, 2026.

Staten Island, N.Y. – September 17, 2026 -- Acurx Pharmaceuticals (NASDAQ: ACXP) presented new in vitro data showing its lead antibiotic ibezapolstat achieved a 5.51-log reduction against Clostridioides difficile in co-culture with vancomycin-resistant Enterococcus (VRE), significantly outperforming vancomycin (p=0.0112), the current standard of care.

The poster, presented by Dr. Eugenie Bassères of the University of Houston College of Pharmacy, was unveiled at the 9th International C. difficile Symposium in Bled, Slovenia, held September 8-10, 2026.